BiotechTube

LY2828360 + Placebo

Phase 2Completed
0 watching 0 views this week⚡ Active
52
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Osteoarthritis, Knee

Conditions

Osteoarthritis, Knee

Trial Timeline

Mar 1, 2011 → Sep 1, 2011

NCT ID
NCT01319929

About LY2828360 + Placebo

LY2828360 + Placebo is a phase 2 stage product being developed by Eli Lilly for Osteoarthritis, Knee. The current trial status is completed. This product is registered under clinical trial identifier NCT01319929. Target conditions include Osteoarthritis, Knee.

Hype Score Breakdown

Clinical
17
Activity
12
Company
10
Novelty
5
Community
5

Clinical Trials (1)

NCT IDPhaseStatus
NCT01319929Phase 2Completed

Competing Products

20 competing products in Osteoarthritis, Knee

See all competitors
ProductCompanyStageHype Score
Duloxetine + PlaceboEli LillyPhase 3
77
Investigational Medical Product (IMP) administered in parent studyEli LillyPhase 3
77
Duloxetine + Sugar pillEli LillyApproved
85
UBX0101 or placeboUnity BiotechnologyPre-clinical
15
UBX0101Unity BiotechnologyPhase 1
25
UBX0101Unity BiotechnologyPhase 2
44
UBX0101Unity BiotechnologyPhase 1
25
YH23537 + Celecoxib + YH23537 placeboYuhanPhase 2
52
Sodium hyaluronate + placebo injectionDaiichi SankyoPhase 3
77
ASP7962 + Naproxen + PlaceboAstellas PharmaPhase 2
52
Capsaicin Topical SolutionAstellas PharmaApproved
85
CGS-200-1 + CGS-200-5 + CGS-200 VehicleAstellas PharmaPhase 2
52
MM-II dose I + MM-II dose II + MM-II dose III + Placebo + Placebo + PlaceboSun PharmaceuticalPhase 2
52
Duloxetine + PlaceboShionogiPhase 3
77
DuloxetineShionogiPhase 3
77
ONO-4474 Part A1 + Placebo Part A1 + ONO-4474 Part A2 + Placebo Part A2 + ONO-4474 Part B + Placebo Part B + ONO-4474 Part C + Placebo Part C + ONO-4474 Part D + Placebo Part DOno PharmaceuticalPhase 1
33
ONO-4474 + Placebo matching ONO-4474Ono PharmaceuticalPhase 2
52
Duloxetine + PlaceboEli LillyPhase 3
77
LY3556050 + PlaceboEli LillyPhase 2
52
Eloralintide + PlaceboEli LillyPhase 3
77

Other Products from Eli Lilly

Insulin Glargine + Insulin Lispro Premix (mid-mixture and low-mixture)Approved
85
Olanzapine + PlaceboApproved
85
exenatide and sitagliptin + exenatide and placeboApproved
85
Tirzepatide + PlaceboApproved
85
tadalafilApproved
85